Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH

J Thromb Haemost. 2018 Jun;16(6):1246-1249. doi: 10.1111/jth.14015. Epub 2018 May 8.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Blood Coagulation / drug effects*
  • Evidence-Based Medicine
  • Hemorrhage / chemically induced
  • Humans
  • Neoplasms / blood
  • Neoplasms / complications
  • Neoplasms / diagnosis
  • Neoplasms / drug therapy*
  • Platelet Count
  • Recurrence
  • Risk Assessment
  • Risk Factors
  • Thrombocytopenia / blood
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / etiology*
  • Thrombosis / blood
  • Thrombosis / diagnosis
  • Thrombosis / drug therapy*
  • Thrombosis / etiology
  • Time Factors
  • Treatment Outcome

Substances

  • Anticoagulants
  • Antineoplastic Agents